29.02.2024 13:48 | RENX | Renalytix up as kidneyintelX.dkd authorised for US government contract | Alliance |
29.02.2024 07:00 | RENX | US Government coverage expanded | RNS |
15.02.2024 11:35 | RENX | Renalytix narrows annual loss but cash balance and revenue fall | Alliance |
15.02.2024 07:00 | RENX | Half Year Report | RNS |
09.02.2024 10:36 | RENX | Renalytix up after US CMS issues draft local coverage determination | Alliance |
17.01.2024 07:00 | RENX | Update on kidneyIntelX.dkd LCD Consideration | RNS |
10.01.2024 14:52 | RENX | Renalytix celebrates new data on KidneyIntelX for kidney disease | Alliance |
10.01.2024 07:00 | RENX | New published data for KidneyIntelX™ | RNS |
18.12.2023 07:00 | RENX | Issue of Shares | RNS |
15.12.2023 18:17 | RENX | Result of AGM | RNS |
08.12.2023 18:14 | RENX | Directorate Change | RNS |
08.12.2023 14:54 | ULTP, SREI, RENX | UK shareholder meetings calendar - next 7 days | Alliance |
23.11.2023 07:00 | RENX | Grant of Share Options | RNS |
17.11.2023 15:56 | RENX | Publication of Annual Report 2023 & Notice of AGM | RNS |
14.11.2023 11:38 | RENX | Renalytix shares dive as first quarter revenue halves | Alliance |
14.11.2023 10:59 | RENX, AGY, HZM | AIM WINNERS & LOSERS: Renalytix revenue halves; DP Poland trades well | Alliance |
14.11.2023 07:00 | RENX | Renalytix Reports Financial Results for Q1 FY2024 | RNS |
07.11.2023 15:51 | WISE, VOD, VSVS | UK earnings, trading statements calendar - next 7 days | Alliance |
07.11.2023 07:00 | RENX | Notice of Results | RNS |
30.10.2023 14:37 | RENX | Announcement of AGM and Publication of AR | RNS |
24.10.2023 07:00 | RENX | Directorate change | RNS |
17.10.2023 07:00 | RENX | Issue of Shares | RNS |
06.10.2023 11:04 | RENX | Renalytix hails US Patent Office allowing patent claims for IP | Alliance |
06.10.2023 07:00 | RENX | US Patent Office Allows Patent Claims for IP | RNS |
03.10.2023 15:13 | RENX | Issue of Shares | RNS |
03.10.2023 10:21 | OBD, AURR, RENX | AIM WINNERS & LOSERS: Safestyle plunges as seeks cash injection | Alliance |
03.10.2023 09:47 | RENX | Renalytix says kidneyintelX.dkd test priced at USD950 by US Medicare | Alliance |
03.10.2023 07:00 | RENX | Medicare prices kidneyintelX.dkd at $950 | RNS |
28.09.2023 11:02 | RENX | IN BRIEF: Renalytix annual loss narrows; optimistic on KidneyIntelX | Alliance |
28.09.2023 07:00 | RENX | Renalytix Reports Full Year Fiscal 2023 Results | RNS |
25.09.2023 07:00 | RENX | Notice of Results | RNS |
22.09.2023 14:07 | RENX | IN BRIEF: Renalytix inks Texas contracts expanding insurance coverage | Alliance |
22.09.2023 07:00 | RENX | Payer coverage expansion of KidneyIntelX | RNS |
07.09.2023 20:27 | SEED, LEX, RST | TRADING UPDATES: Tintra receives bid approach; NCC trading in line | Alliance |
07.09.2023 07:00 | RENX | Appointment of Chief Business Officer | RNS |
21.08.2023 10:16 | RENX | Renalytix hails KidneyIntelX inclusion in guidance to evaluate CKD | Alliance |
21.08.2023 07:00 | RENX | Business Update | RNS |
03.08.2023 09:10 | RENX | RSU vesting for employees | RNS |
03.08.2023 07:00 | RENX | Formation of Clinical Advisory Board | RNS |
21.07.2023 10:40 | RENX, FTC, BLVN | AIM WINNERS & LOSERS: Bowleven says fundraising efforts continue | Alliance |
21.07.2023 09:31 | RENX | Renalytix & Vector Pharma sign Middle East distribution deal | Alliance |
21.07.2023 07:00 | RENX | Vector Pharma Middle East Distribution Agreement | RNS |
17.07.2023 13:43 | RENX | Issue of Shares - Replacement | RNS |
17.07.2023 07:00 | RENX | Issue of Shares | RNS |
07.07.2023 07:00 | RENX | KidneyIntelX evidence presented at ADA | RNS |
06.07.2023 17:38 | RENX | Grant of Share Options | RNS |
03.07.2023 07:00 | RENX | Directorate Change | RNS |
30.06.2023 10:48 | RENX, HMI | AIM WINNERS & LOSERS: Harvest Minerals slashes annual sales forecast | Alliance |
30.06.2023 10:20 | RENX | Renalytix shares soar on FDA testing platform approval | Alliance |
30.06.2023 07:00 | RENX | FDA Approves KidneyIntelX.dkd™ | RNS |
15.06.2023 07:00 | RENX | Presentation of Scientific Data | RNS |
09.06.2023 14:30 | RENX | Renalytix loss widens, revenue affected by disruption to testing | Alliance |
09.06.2023 07:00 | RENX | Financial Results for Q3 of Fiscal Year 2023 | RNS |
08.06.2023 15:30 | RENX | Result of General Meeting | RNS |
05.06.2023 07:00 | RENX | Notice of Q3 Results | RNS |
01.06.2023 15:52 | EGY, RENX, PALM | UK shareholder meetings calendar - next 7 days | Alliance |
25.05.2023 12:14 | RENX | IN BRIEF: Renalytix picks Eversana to commercialise prognostic device | Alliance |
25.05.2023 07:00 | RENX | EVERSANA® partnership for KidneyIntelX | RNS |
22.05.2023 16:10 | POW, RENX, PFP | TRADING UPDATES: Catenae hails court; Golden Metals likes copper find | Alliance |
22.05.2023 07:00 | RENX | Expansion of insurance coverage for KidneyIntelX | RNS |
11.05.2023 07:00 | RENX | Notice of GM and Posting of Circular | RNS |
19.04.2023 11:47 | RENX | Renalytix says review results show utility of bioprognostic tool | Alliance |
19.04.2023 07:00 | RENX | Real-World Evidence Shows KidneyIntelX™ Utility | RNS |
12.04.2023 11:57 | RENX | IN BRIEF: Renalytix to present data on efficacy of KidneyIntelX | Alliance |
12.04.2023 07:00 | RENX | Positive Data Release at NKF Conference | RNS |
30.03.2023 18:39 | BVX, PTAL, RENX | EARNINGS UPDATES: Ironveld sees interim pretax loss widen on costs | Alliance |
30.03.2023 07:00 | RENX | Half-year Report | RNS |
27.03.2023 12:50 | RENX | Business Update - Replacement | RNS |
27.03.2023 12:04 | RENX | Renalytix ups insurance coverage base in Northeast US via EmblemHealth | Alliance |
27.03.2023 07:00 | RENX | Business Update | RNS |
23.03.2023 15:47 | XLM, SUPR, STB | UK earnings, trading statements calendar - next 7 days | Alliance |
22.03.2023 07:00 | RENX | Notice of Results | RNS |
21.03.2023 20:18 | NSI, RENX, GPL | TRADING UPDATES: React Group optimistic; Cindrigo inks financing | Alliance |
21.03.2023 14:05 | RENX | Second Price Monitoring Extn | RNS |
21.03.2023 14:00 | RENX | Price Monitoring Extension | RNS |